You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Bayer buys Calif. birth control firm

FRANKFURT — German drug company Bayer AG says it has agreed to buy California-based Conceptus for around $1.1 billion to expand the kinds of birth control it ­offers.

Bayer said Monday it would launch a public offer to pay $31 per share for all the stock in Conceptus Inc., which is based in Mountain View.

Continue reading below

Conceptus makes Essure, an irreversible birth control method in which small metal and polyester coils are inserted to block a woman’s fallopian tubes. The procedure can be done in 10 minutes in a doctor’s office.

Bayer already markets birth control pills and intrauterine devices. Chief executive Marijn Dekkers said that the deal represented a ‘‘strategic bolt-on acquisition’’ and that it was an ‘‘excellent fit in the United States, the world’s most important health care market.’’

Conceptus chief executive D. Keith Grossman was quoted in a Bayer statement as saying Essure ‘‘will benefit in new markets from Bayer’s global presence.’’

The deal is subject to approval by antitrust authorities and could be completed by midyear.

Conceptus employs about 300 people. Bayer has about 112,000 employees and is based in Leverkusen, ­Germany.

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of